New imaging agent spots hidden breast cancer tumors
NCT ID NCT04758780
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tested a new radioactive tracer called 89Zr-TLX250 that attaches to a protein found on some triple negative breast cancer cells. 12 people with advanced cancer received a PET scan using this new tracer, and doctors compared it to a standard PET scan to see which one found more tumors, especially in the brain. The goal was to see if this new imaging method could help doctors better understand where the cancer has spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICO René Gauducheau
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.